SS Innovations International, Inc. (NASDAQ: SSII) announced it has been named the winner of the Outstanding Company category at the 2026 Surgical Robotics Industry Awards, recognizing the company’s excellence in innovation, commercial success, industry leadership and positive societal impact. The award reflects growing adoption of its SSi Mantra surgical robotic system, which the company believes is gaining traction for its advanced technology, user-friendly design, training capabilities and cost efficiency.
As of June 22, 2026, SS Innovations reported that 11,719 multi-specialty procedures had been performed using the SSi Mantra system, including 612 cardiac procedures, 175 telesurgeries and 212 pediatric surgeries. The company also stated that approximately 2,100 physicians have been trained on the platform, which has been used for more than 170 procedure types and has received regulatory approval in 14 countries.
The award underscores the company’s mission to make robotic surgery affordable and accessible globally. SS Innovations develops innovative surgical robotic technologies, with its product range including the SSi Mantra surgical robotic system and the SSi Mudra surgical instruments, which support a variety of procedures including cardiac surgery. An American company headquartered in India, SS Innovations plans to expand the global presence of its cost-effective surgical robotic solutions.
For more information, visit the company’s website at ssinnovations.com. To view the full press release, visit https://ibn.fm/XWdRe.
